Application Nr Approved Date Route Status External Links
NDA212516 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Drizalma Sprinkle Is Indicated For The Treatment Of: • Major Depressive Disorder In Adults [See Clinical Studies (14.1)] • Generalized Anxiety Disorder In Adults And Pediatric Patients 7 Years To 17 Years Old [See Clinical Studies (14.2)] • Diabetic Peripheral Neuropathy In Adults [See Clinical Studies (14.3)] Chronic Musculoskeletal Pain In Adults [See Clinical Studies (14.4)] Drizalma Sprinkle Is A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: • Major Depressive Disorder (Mdd) In Adults (1) • Generalized Anxiety Disorder (Gad) In Adults And Pediatric Patients Ages 7 Years To 17 Years Old (1) • Diabetic Peripheral Neuropathic Pain (Dpnp) In Adults (1) • Chronic Musculoskeletal Pain In Adults (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments